Clinical Work of the Carmel Medical Center Pharmacy Unit

Speaker(s)

ABSTRACT WITHDRAWN

Presentation Documents

OBJECTIVES: Clinical work of the Carmel Medical Center pharmacy services system. The pharmacy unit at Carmel Medical Center includes l BSc, MSc, PharmD pharmacists.

METHODS: Clinical consultations given by the pharmacists in the first half of 2022 were mapped.

RESULTS: Clinical consultations given by the pharmacists in the first half of 2022 were mapped.

We reviewed the instructions, entered the patients' Electronic health record The selected categories of intervention are medication reconciliation, anticoagulant treatment, antibiotic treatment, therapeutic doubling, adjustment of medication for patients with decreased renal function, counseling on intravenous feeding, medications during breastfeeding, adjustment of medication after bariatric surgery, hematology clinic, polypharmacy, TDM therapeutic drug monitoring.

During the first median, 658 consultations were given in the departments. 24% of the consultations given were regarding the drug treatment regimen of antibiotics, 20% with anticoagulants, 16% medication reconciliation, 8% medication dose adjustment for patients with decreased renal function. The pharmacists also performed 2942 pharmacy assessments in the hospital.

It was possible to see that only 66 percent of the consultations were accepted by the doctor and any changes in the medication were made.

Following this data, a refresher training on medication reconciliation was carried out for the entire staff of the pharmacy unit by a clinical pharmacist.

In the second quarter, following the intervention, 89 percent of the consultations were accepted by the doctors and a change of instruction was made.

CONCLUSIONS: It can be seen that clinical consultations of the pharmacy system influence the medication treatment in hospitalization. The consultation is important for the improvement and the high quality of medical treatment.

Code

HSD26

Topic

Clinical Outcomes

Topic Subcategory

Clinical Outcomes Assessment

Disease

Drugs, No Additional Disease & Conditions/Specialized Treatment Areas